Physician profile
Sachin Logani
NPI 1295997260
$1,325.13
in general payments reported to CMS, 2019-2025
19 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $239 · 2021: $95.59 · 2022: $134 · 2023: $200 · 2024: $174 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $238.90 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $169.72 | 2023-2025 | |
| Amgen INC. | $160.18 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $136.01 | 2019-2020 | |
| Pfizer INC. | $116.08 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.94 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $99.88 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $74.25 | 2020-2023 | Camzyos, Eliquis |
| Corvista Health, INC. | $51.74 | 2025 | Corvista System |
| Amarin Pharma, INC. | $24.63 | 2020 | |
| Esperion Therapeutics, INC. | $19.87 | 2021 | |
| Corcept Therapeutics | $19.75 | 2024 | Korlym |
| Philips North America LLC | $19.22 | 2023 | |
| Jazz Pharmaceuticals INC. | $16.69 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.33 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.16 | 2019 | |
| Mylan Specialty L.P. | $14.47 | 2024 | Yupelri |
| Merck Sharp & Dohme LLC | $13.41 | 2023 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Logani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.